Read the latest Regulatory Transactions Alert from John O'Loughlin and Christina Carone: Proposed BIOSECURE Act Targets Chinese Biotech Firms – Could Disrupt Life Sciences Supply Chains in the Federal Sector – https://lnkd.in/eiqxeqxd
Weil, Gotshal & Manges LLP’s Post
More Relevant Posts
-
Have you downloaded the 2023 Horizons: Life Sciences report? It’s not too late to get all the insights into the current and future state the life sciences industry. We asked and more than 500 industry professionals answered with the trends and challenges they are currently facing. Their insights combined with in-depth analysis from CRB’s leading experts, this report is a must-have for anyone who works in the life sciences industry. Download it for free here: https://hubs.la/Q021S-DY0 For a preview, check out Peter Walter’s Q&A with BioPharma-Reporter at the link below. #LifeSciences #Biopharma #PharmaceuticalManufacturing #Biotech #Industry40 #CRBHorizons
To view or add a comment, sign in
-
🇪🇺 EU Biotech Act: 3 Key Points 🧬 In this quick video, I'm listing the three main points of the new EU Biotech Act: * Unified legislation * More investment (public and private) * EU Biotech Hub Want to know more? Just comment "biotech" below, and we'll talk about it in depth next time. I've checked the official EU document to make sure these points are spot-on. It's a big deal for biotech in Europe, but we'll keep it simple for now.
To view or add a comment, sign in
-
Have you downloaded the 2023 Horizons: Life Sciences report? It’s not too late to get all the insights into the current and future state the life sciences industry. We asked and more than 500 industry professionals answered with the trends and challenges they are currently facing. Their insights combined with in-depth analysis from CRB’s leading experts, this report is a must-have for anyone who works in the life sciences industry. Download it for free here: https://hubs.la/Q021S-DY0 For a preview, check out Peter Walter’s Q&A with BioPharma-Reporter at the link below. #LifeSciences #Biopharma #PharmaceuticalManufacturing #Biotech #Industry40 #CRBHorizons
Q&A: CRB on the future of life sciences industry
share.postbeyond.com
To view or add a comment, sign in
-
Have you downloaded the 2023 Horizons: Life Sciences report? It’s not too late to get all the insights into the current and future state the life sciences industry. We asked and more than 500 industry professionals answered with the trends and challenges they are currently facing. Their insights combined with in-depth analysis from CRB’s leading experts, this report is a must-have for anyone who works in the life sciences industry. Download it for free here: https://hubs.la/Q021S-DY0 For a preview, check out Peter Walter’s Q&A with BioPharma-Reporter at the link below. #LifeSciences #Biopharma #PharmaceuticalManufacturing #Biotech #Industry40 #CRBHorizons
Q&A: CRB on the future of life sciences industry
share.postbeyond.com
To view or add a comment, sign in
-
Have you downloaded the 2023 Horizons: Life Sciences report? It’s not too late to get all the insights into the current and future state the life sciences industry. We asked and more than 500 industry professionals answered with the trends and challenges they are currently facing. Their insights combined with in-depth analysis from CRB’s leading experts, this report is a must-have for anyone who works in the life sciences industry. Download it for free here: https://hubs.la/Q021S-DY0 For a preview, check out Peter Walter’s Q&A with BioPharma-Reporter at the link below. #LifeSciences #Biopharma #PharmaceuticalManufacturing #Biotech #Industry40 #CRBHorizons
Q&A: CRB on the future of life sciences industry
share.postbeyond.com
To view or add a comment, sign in
-
Current pending legislation, known as the BIOSECURE Act, could prevent Chinese biotech companies from conducting business in the U.S. — but what would this mean for Massachusetts, one of the world’s most iconic biotech clusters? In our latest blog post, learn about the BIOSECURE Act, its status in U.S. Congress, and the potential impact on Massachusetts. https://bit.ly/4clYp02 #IssuesGroup
What could the BIOSECURE Act mean for commercial real estate in Massachusetts?
issuesgroup.com
To view or add a comment, sign in
-
Have you downloaded the 2023 Horizons: Life Sciences report? It’s not too late to get all the insights into the current and future state the life sciences industry. We asked and more than 500 industry professionals answered with the trends and challenges they are currently facing. Their insights combined with in-depth analysis from CRB’s leading experts, this report is a must-have for anyone who works in the life sciences industry. Download it for free here: https://hubs.la/Q021S-DY0 For a preview, check out Peter Walter’s Q&A with BioPharma-Reporter at the link below. #LifeSciences #Biopharma #PharmaceuticalManufacturing #Biotech #Industry40 #CRBHorizons
Q&A: CRB on the future of life sciences industry
share.postbeyond.com
To view or add a comment, sign in
-
Great insight for the life sciences industry outlook.
We are happy to announce the publication of our 'United States Life Sciences 2024' Print Release! Despite facing challenges like regulatory shifts and geopolitical tensions, the industry is on a path to recovery after a tough 2023. With the US retaining its leadership in global pharmaceuticals and drawing in foreign investment, the report underscores today's landscape and the industry's resilience. Find out key insights gleaned from nearly a hundred interviews with executives from biopharma, biotech, investors, CDMOs, CROs, specialty chemicals, technology, and AI sectors. Read the report here: https://lnkd.in/gpJgTG_7 Special thanks to our partners MassBio, BioNJ, Biocom California, and CPHI for their invaluable support in making it happen! The report is currently being distributed at #BIO2024 in San Diego. Reach out to grab a copy! #USALifeSciences #GBR #PharmaceuticalIndustry #CDMOs #BioPharma
To view or add a comment, sign in
-
-
In 1 month, biopharma leaders, regulators, investors and scientists will gather at the FT Live US Pharma and Biotech Summit @endpoints news Join the Summit to learn how the new market cycle will finance the next period of investing in innovation, debate the dueling approaches to the US life expectancy crisis and hear how artificial intelligence is splitting into two technological camps. Save 20% on your in-person or digital pass with discount code NYBIO https://bit.ly/49lvk2X #FTPharma
To view or add a comment, sign in
-
-
In our winter #lifesciences outlook, we examine: ⇛ Easing funding concerns for #biotechs ⇛ Global clinical trial challenges ⇛ Resilient revenue trends for #medtech
2024 life sciences industry outlook
rsmbuzz.com
To view or add a comment, sign in